Open Source Imaging Consortium (OSIC)OSIC – a global, 501(c)(3), not-for-profit cooperative effort between academia, industry and patient advocacy groups – was created to enable rapid, open source advances in the fight against idiopathic pulmonary fibrosis (IPF), fibrosing interstitial lung diseases (ILDs), and other respiratory diseases, including emphysematous conditions.
Our MissionOSIC brings together radiologists, clinicians, computational scientists, and industry competitors from around the world to advance digital imaging biomarkers for accurate imaging-based diagnosis, prognosis and prediction of response to therapy.
The partners work in pre-competitive areas for mutual benefit and, most importantly, the benefit of patients. |
|
The largest and most diverse ILD database in the worldGOAL SURPASSED
15,000 anonymized scans with accompanying clinical data COMMITTED TO DATE
20,752 anonymized scans with accompanying clinical data from Northern Europe, Western Europe, Central & Eastern Europe, North America, South America, and Asia-Pacific (APAC) |
OSIC 2023 AI/Biomarker
Innovation Showcase Curated Data and Progresson Novel Biomarkers |